| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maplight Therapeutics, Inc. (MPLT) has 13 insiders with recent SEC Form 4 filings, including 5 buys and 6 sells. MPLT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 14.26M | $390.62M | - | |
| 10% | 2.73M | $74.90M | - | |
| CEO | 1.63M | $44.57M | - | |
| Other | 390.5K | $10.70M | - | |
| CFO | 387.8K | $10.63M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Pavlov George | Director | Buy | 25,000 | $17.65 | $441,167.58 | +97.1% | - | - | |
| Feb 3, 2026 | Malenka Robert C. | Director | Sell | 7,040 | $18.02 | $126,860.78 | -1.0% | +79.4% | - | |
| Jan 30, 2026 | Malenka Robert C. | Director | Sell | 34,398 | $18.49 | $635,857.22 | -2.2% | +80.2% | - | |
| Oct 28, 2025 | Catalyst4, Inc. | 10% Owner | Buy | 5,441,176 | $17.00 | $92,499,992.00 | +38.2% | +7.3% | - | |
| Oct 28, 2025 | Novo Holdings A/s58 | 10% Owner | Buy | 952,941 | $17.00 | $16,199,997.00 | +34.9% | +7.3% | - |